• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估估计心理健康障碍患病率的研究偏倚风险的工具 (RoB-PrevMH)。

Tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH).

机构信息

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

出版信息

BMJ Ment Health. 2023 Oct;26(1). doi: 10.1136/bmjment-2023-300694.

DOI:10.1136/bmjment-2023-300694
PMID:37899074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10619100/
Abstract

OBJECTIVE

There is no standard tool for assessing risk of bias (RoB) in prevalence studies. For the purposes of a living systematic review during the COVID-19 pandemic, we developed a tool to evaluate RoB in studies measuring the prevalence of mental health disorders (RoB-PrevMH) and tested inter-rater reliability.

METHODS

We decided on items and signalling questions to include in RoB-PrevMH through iterative discussions. We tested the reliability of assessments by different users with two sets of prevalence studies. The first set included a random sample of 50 studies from our living systematic review. The second set included 33 studies from a systematic review of the prevalence of post-traumatic stress disorders, major depression and generalised anxiety disorder. We assessed the inter-rater agreement by calculating the proportion of agreement and Kappa statistic for each item.

RESULTS

RoB-PrevMH consists of three items that address selection bias and information bias. Introductory and signalling questions guide the application of the tool to the review question. The inter-rater agreement for the three items was 83%, 90% and 93%. The weighted kappa scores were 0.63 (95% CI 0.54 to 0.73), 0.71 (95% CI 0.67 to 0.85) and 0.32 (95% CI -0.04 to 0.63), respectively.

CONCLUSIONS

RoB-PrevMH is a brief, user-friendly and adaptable tool for assessing RoB in studies on prevalence of mental health disorders. Initial results for inter-rater agreement were fair to substantial. The tool's validity, reliability and applicability should be assessed in future projects.

摘要

目的

目前尚无评估流行性病学研究偏倚风险(RoB)的标准工具。为在 COVID-19 大流行期间进行实时系统评价,我们开发了一种用于评估精神健康障碍患病率研究的 RoB(RoB-PrevMH)的工具,并测试了其信度。

方法

我们通过反复讨论决定将 RoB-PrevMH 的纳入项目和信号问题。我们通过两组患病率研究来测试不同使用者评估的可靠性。第一组包括我们实时系统评价中的 50 项随机研究。第二组包括创伤后应激障碍、重度抑郁症和广泛性焦虑障碍患病率系统评价中的 33 项研究。我们通过计算每个项目的一致性比例和 Kappa 统计量来评估组内一致性。

结果

RoB-PrevMH 由三个评估选择偏倚和信息偏倚的项目组成。引言和信号问题指导该工具在审查问题中的应用。三个项目的组内一致性分别为 83%、90%和 93%。加权 Kappa 评分分别为 0.63(95%CI 0.54-0.73)、0.71(95%CI 0.67-0.85)和 0.32(95%CI -0.04-0.63)。

结论

RoB-PrevMH 是一种用于评估精神健康障碍患病率研究 RoB 的简洁、用户友好且可适应的工具。初始组内一致性结果为适度至极好。该工具的有效性、可靠性和适用性应在未来的项目中进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/10619100/8063f24e236b/bmjment-2023-300694f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/10619100/8063f24e236b/bmjment-2023-300694f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/10619100/8063f24e236b/bmjment-2023-300694f01.jpg

相似文献

1
Tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH).评估估计心理健康障碍患病率的研究偏倚风险的工具 (RoB-PrevMH)。
BMJ Ment Health. 2023 Oct;26(1). doi: 10.1136/bmjment-2023-300694.
2
A tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH).一种评估估算心理健康障碍患病率研究的偏倚风险的工具(心理健康障碍患病率偏倚风险评估工具)
medRxiv. 2023 Feb 2:2023.02.01.23285335. doi: 10.1101/2023.02.01.23285335.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
The Ultrashort Mental Health Screening Tool Is a Valid and Reliable Measure With Added Value to Support Decision-making.超短心理健康筛查工具具有有效性和可靠性,并且具有附加价值,可以支持决策。
Clin Orthop Relat Res. 2024 Jan 1;482(1):59-70. doi: 10.1097/CORR.0000000000002718. Epub 2023 Jun 20.
5
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
6
Breastfeeding interventions for preventing postpartum depression.预防产后抑郁症的母乳喂养干预措施。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD014833. doi: 10.1002/14651858.CD014833.pub2.
7
Interventions for preventing falls in older people in care facilities.护理机构中预防老年人跌倒的干预措施。
Cochrane Database Syst Rev. 2025 Aug 20;8:CD016064. doi: 10.1002/14651858.CD016064.
8
Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.在一项关于长效β-激动剂和吸入性皮质类固醇联合治疗持续性哮喘的系统评价中应用偏倚风险工具。
PLoS One. 2011 Feb 24;6(2):e17242. doi: 10.1371/journal.pone.0017242.
9
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
10
Generalized Anxiety Disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults.用于检测成人焦虑症的广泛性焦虑障碍7项(GAD - 7)和2项(GAD - 2)量表。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015455. doi: 10.1002/14651858.CD015455.

引用本文的文献

1
How many specialists and residents in Clinical Psychology are required in the Spanish National Health System? A needs-based study.西班牙国家卫生系统需要多少临床心理学专家和住院医生?一项基于需求的研究。
Hum Resour Health. 2025 Aug 26;23(1):46. doi: 10.1186/s12960-025-01017-z.
2
Revictimisation Across Types of Interpersonal Violence: A Meta-Regression Analysis of PTSD and Associated Factors.各类人际暴力中的再次受害:创伤后应激障碍及相关因素的元回归分析
Stress Health. 2025 Aug;41(4):e70079. doi: 10.1002/smi.70079.
3
Suicide risk in patients undergoing hemodialysis: a systematic review and meta-analysis of prevalence.

本文引用的文献

1
Studies of prevalence: how a basic epidemiology concept has gained recognition in the COVID-19 pandemic.研究流行率:一个基本的流行病学概念如何在 COVID-19 大流行中得到认可。
BMJ Open. 2022 Oct 27;12(10):e061497. doi: 10.1136/bmjopen-2022-061497.
2
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysis.**新冠疫情和相关防控措施对一般人群心理健康的影响**:系统评价和剂量反应荟萃分析。
Ann Intern Med. 2022 Nov;175(11):1560-1571. doi: 10.7326/M22-1507. Epub 2022 Oct 18.
3
Mental health of migrants with pre-migration exposure to armed conflict: a systematic review and meta-analysis.
接受血液透析患者的自杀风险:患病率的系统评价与荟萃分析
Ren Fail. 2025 Dec;47(1):2521453. doi: 10.1080/0886022X.2025.2521453. Epub 2025 Jun 26.
4
Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis.停用抗抑郁药后的急性戒断后综合征(PAWS):一项采用元叙事综合法的系统评价
Epidemiol Psychiatr Sci. 2025 May 13;34:e29. doi: 10.1017/S204579602500023X.
5
PROTOCOL: Prevalence and Risk and Protective Factors for Radicalization Among School-Aged Youth: A Systematic Review.方案:学龄青年激进化的患病率、风险及保护因素:一项系统综述。
Campbell Syst Rev. 2025 Apr 24;21(2):e70041. doi: 10.1002/cl2.70041. eCollection 2025 Jun.
6
The Prevalence of Excessive Exercise in Eating Disorders: A Systematic Review and Meta-Analysis.饮食失调中过度运动的患病率:一项系统评价和荟萃分析。
Eur Eat Disord Rev. 2025 Sep;33(5):1005-1016. doi: 10.1002/erv.3194. Epub 2025 Apr 19.
7
Changes in the prevalence of mental health problems during the first year of the pandemic: a systematic review and dose-response meta-analysis.大流行第一年期间心理健康问题的患病率变化:系统评价和剂量-反应荟萃分析。
BMJ Ment Health. 2024 Jun 13;27(1):e301018. doi: 10.1136/bmjment-2024-301018.
8
In-Hospital Neurologic Complications, Neuromonitoring, and Long-Term Neurologic Outcomes in Patients With Sepsis: A Systematic Review and Meta-Analysis.脓毒症患者的住院期神经系统并发症、神经监测和长期神经系统结局:系统评价和荟萃分析。
Crit Care Med. 2024 Mar 1;52(3):452-463. doi: 10.1097/CCM.0000000000006096. Epub 2023 Nov 3.
迁移前经历过武装冲突的移民的心理健康:一项系统评价与荟萃分析。
Lancet Public Health. 2022 May;7(5):e469-e481. doi: 10.1016/S2468-2667(22)00061-5.
4
Meta-analysis of prevalence: I statistic and how to deal with heterogeneity.患病率的Meta分析:I统计量及异质性处理方法
Res Synth Methods. 2022 May;13(3):363-367. doi: 10.1002/jrsm.1547. Epub 2022 Feb 23.
5
An efficient way to assess the effect of COVID-19 on mental health in the general population.一种评估新冠病毒病对普通人群心理健康影响的有效方法。
Lancet Psychiatry. 2021 May;8(5):e14-e15. doi: 10.1016/S2215-0366(21)00067-5. Epub 2021 Mar 16.
6
Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus.新发传染病出版物的爆发:以 SARS-CoV-2 和寨卡病毒为例。
BMC Med Res Methodol. 2021 Mar 11;21(1):50. doi: 10.1186/s12874-021-01244-7.
7
A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health.一项关于新冠疫情对心理健康影响的实时元生态研究。
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):219-221. doi: 10.1007/s00406-021-01242-2.
8
Quality assessment of prevalence studies: a systematic review.患病率研究的质量评估:系统评价。
J Clin Epidemiol. 2020 Nov;127:59-68. doi: 10.1016/j.jclinepi.2020.06.039. Epub 2020 Jul 15.
9
COVID-19: The first documented coronavirus pandemic in history.COVID-19:历史上有记录的首例冠状病毒大流行。
Biomed J. 2020 Aug;43(4):328-333. doi: 10.1016/j.bj.2020.04.007. Epub 2020 May 5.
10
How are systematic reviews of prevalence conducted? A methodological study.如何进行患病率的系统评价?一项方法学研究。
BMC Med Res Methodol. 2020 Apr 26;20(1):96. doi: 10.1186/s12874-020-00975-3.